2 recruiting, 2 unknown, 1 completed. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 2, Unknown 2, Completed 1 |
Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism The multifaceted interventions, Routine VTE prophylaxis - Venous Thromboembolic Disease, Pulmonary Embolism | Not applicable | Recruiting | China-Japan Friendship Hospital | 5800 | 2025-08-01 | 2025-09-17 |
| Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) - Lymphoma, Leukemia | Not applicable | Recruiting | Medical University of Gdansk | 100 | 2024-11-22 | 2025-12-26 |
| Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism EHR (electronic health record) alert, No EHR (electronic health record) alert - Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis | Not applicable | Unknown | Scott C. Woller, MD | 152000 | 2024-06-01 | 2024-07-17 |
| CHIPs-VTE Study in Hospitalized Patients With Lung Cancer Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge, Routine VTE prophylaxis in hospital - Venous Thromboembolic Disease, Pulmonary Embolism | Not applicable | Unknown | China-Japan Friendship Hospital | 3200 | 2021-12-01 | 2021-08-03 |
| Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter. Bard Recovery G2 Filter System - Pulmonary Embolism, Venous Thromboembolic Disease | Not applicable | Completed | C. R. Bard | 100 | 2005-12-01 | 2012-06-01 |
Pulmonary Embolism (5) · Venous Thrombosis (3) · Venous Thromboembolism (2) · Hematologic Neoplasms (1) · Leukemia (1) · Lymphoma (1) · Multiple Myeloma (1) · Thrombosis (1)
Cardiovascular Diseases (5) · Embolism (5) · Embolism and Thrombosis (5) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Vascular Diseases (5) · Thromboembolism (2) · Thrombosis (2) · Blood Protein Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Caffeine (1) · Electronic Health Records (1) · Enoxaparin (1) · Heparin, Low-Molecular-Weight (1) · Hospitals (1) · Rivaroxaban (1) · apixaban (1) · enoxaparin sodium (1)
China-Japan Friendship Hospital (2) · C. R. Bard (1) · Medical University of Gdansk (1) · Scott C. Woller, MD (1)
China (1) · Poland (1) · United States (1)
Zhenguo Zhai, Doctor (2) · John A Kaufman, MD (1) · Scott C. Woller, MD (1)